Purchase Order 75N93019P00187
- Not listed
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to Bachem Americas, Inc. for the custom synthesis of 20 mg peptides with >95% purity, including quality control analytical services. The contract ceiling value is $4,315.00 and the ultimate completion date is March 26, 2016. Bachem Americas, Inc. is a foreign-owned, for-profit manufacturer of pharmaceutical ingredients...
- This federal contract award, identified as HHSN272201500430P, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the U.S. Department of Health and Human Services, to the prime contractor Atlantic Peptides LLC. The contract is for the purchase of a set of 30 peptides, each at 1 milligram and 75% purity, for a fixed price of $3,900.00. The contract has a completion date of April 3, 2015 and was awarded on March 4, 2015. No set-aside designation is...
- The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $28,000 firm fixed price purchase order to Karebay Biochem Inc. under request for quotes RFQ-NIAID-23-2175814. The contract calls for the delivery of a peptide library consisting of 408 peptides, each with 1 milligram of a 15 amino acid peptide at 95% purity. The place of performance is China. The award was set aside for total small business and will...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The award, valued at $14,994, is for the delivery of 5,400 crude peptides by A & A LABS LLC, also doing business as Synthetic Biomolecules. The contract does not have a set-aside designation. A & A LABS LLC is a minority-owned, small disadvantaged business. This contract award may support NIAID's...
- The U.S. National Institute of Allergy and Infectious Diseases (NIAID) awarded a Firm Fixed Price Purchase Order contract to Asischem Inc. to provide custom synthesis of a chemical compound. The contract, valued at $4,890.00, was awarded on August 3, 2015 with a completion date of December 1, 2015. This contract was not set aside for any specific business type or size. Based on the agency name, this contract is likely related to NIAID's research and development programs focused on infectious...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $32,610 firm fixed price purchase order to JPT Peptide Technologies GmbH of Germany. The contract is to provide 20 units of a 158-peptide mixture and 25 units of a 102-peptide mixture related to the SARS-CoV-2 spike glycoprotein and nucleocapsid phosphoprotein, respectively, as referenced in the original solicitation. The peptides will support ongoing NIAID...
- The National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), awarded a $6,560 firm-fixed-price purchase order to Pepscan Presto B.V., a foreign-owned, for-profit organization, for custom peptide synthesis services. The award, which had a performance period ending on September 30, 2015, was not set aside for any specific business category. Pepscan Presto B.V. is a premier provider of peptide-based products and services with...
- This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to A & A Labs LLC, doing business as Synthetic Biomolecules. The $8,482.00 contract is for the custom synthesis of 15-mer peptides. The contract is set aside for small businesses and the awardee is a minority-owned, self-certified small disadvantaged business. The place of performance is San Diego,...
- The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $11,453 purchase order to Genscript USA Inc. to provide custom peptide synthesis services in support of H1/HA programs. The firm fixed price contract runs from September 18, 2023 through December 29, 2023 and will be performed in Piscataway, New Jersey. Genscript will synthesize peptides to advance NIH's research on influenza viruses under the contract....
- This is a $36,000.00 firm fixed-price contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which is part of the National Institutes of Health (NIH), a civilian agency. The contract was awarded to Entrechem SL, a for-profit manufacturer located in Spain, to provide 100g each of two specialized chemical compounds, (1S,2S)-trans-N-Boc-Tetrahydro-3,4-furandiamine and (1R,2R)-trans-N-Boc-Tetrahydro-3,4-furandiamine. These compounds are needed as starting...
The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm-fixed-price purchase order contract to Bachem Americas, Inc., a foreign-owned, for-profit manufacturer of pharmaceutical ingredients, to provide 1 gram of RON2 acetate salt peptide. The contract has a potential value of $45,750.00 and a completion date of January 18, 2019. The procurement was a sole-source award based on Bachem's status as the only responsible source capable of meeting the government's requirements. No set-aside designation was specified. This contract supports NIAID's drug development and manufacturing programs at the National Center for Advancing Translational Sciences.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
RON2 acetate salt | NOI-RML-C-1940131 | Department of Health and Human Services National Institutes of Health | Solicitation 1/1 | 12/19/18, 10:20 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $45.8k | 12/27/18 |